DLR German Aerospace Center   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Cologne Germany (1969)

Organization Overview

First Clinical Trial
2007
NCT01655953
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

DLR German Aerospace Center

Active Ingredients

Drugs in Phase 3 Trials (2)

morphine (1 trial)

triamcinolone (kenalog) (1 trial)

Drugs in Phase 2 Trials (2)

sacubitril (Entresto) (1 trial)

valsartan (diovan) (1 trial)

Drugs in Phase 1 Trials (1)

cd20 car-t cells (1 trial)

Drugs in Other Trials (4)

bicarbonate (1 trial)

lupin protein (2 trials)

sodium bicarbonate (2 trials)

whey protein (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 3)

Heart Failure (Phase 2)

Melanoma (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 8
  • # of Trial APIs: 9